Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer

NCT02418624 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Ovarian Cancer
Advanced Cancer

Interventions

DRUG: carboplatin, olaparib

Sponsor

The Netherlands Cancer Institute